Target intelligence / Profile preview

Plasmodium apicoplast 50S ribosome (Apicoplast 50S)

Target
Apicoplast 50S
Molecular classification
Ribosome, Ribonucleoprotein complex
01

Overview

The Plasmodium apicoplast 50S ribosome is the large subunit of the prokaryotic-like 70S ribosome located within the apicoplast, a non-photosynthetic plastid essential for the survival of malaria-causing parasites (McFadden, 2011; Sidhu et al., 2007). This organelle, derived from an ancient red algal endosymbiont, houses critical metabolic pathways such as isoprenoid biosynthesis, which are vital for the parasite's asexual blood stage (Yeh and DeRisi, 2011). The 50S subunit serves as a primary target for several classes of antibiotics, including macrolides like azithromycin and lincosamides like clindamycin (Dahl and Rosenthal, 2007). These drugs bind to the subunit, typically at the peptide exit tunnel or the peptidyl transferase center, thereby inhibiting protein translation (Sidhu et al., 2007). A hallmark of targeting the apicoplast ribosome is the "delayed death" phenomenon, where the initial generation of parasites remains viable but their progeny fail to survive, necessitating the use of these drugs in combination with faster-acting antimalarials (Dahl and Rosenthal, 2007; Kennedy et al., 2019). Resistance to these agents can emerge through specific mutations in apicoplast-encoded components, such as the 23S ribosomal RNA or the ribosomal protein L4 (Goodman et al., 2013; Sidhu et al., 2007). Understanding the structural and functional nuances of this ribosome is crucial for developing next-generation antimalarials that can overcome existing resistance mechanisms (Gupta et al., 2014).

Other names
Apicoplast large ribosomal subunitApicoplast 50S subunitLSU of apicoplast ribosomePlasmodium falciparum apicoplast 50S ribosome
02

Mechanism of action

Inhibition of protein synthesis by binding to the 50S ribosomal subunit, specifically at the peptide exit tunnel or peptidyl transferase center, to block transpeptidation and peptide elongation (Sidhu et al., 2007; Dahl and Rosenthal, 2007).

03

Biological functions

Protein translationMetabolic processIsoprenoid biosynthesis support
04

Disease associations

InfectionMalaria
05

Safety considerations

Delayed death phenotype (slow onset of action)Development of drug resistanceRequirement for combination with fast-acting antimalarials
06

Interacting drugs

Azithromycin

4 more in the full profile.

07

Biomarkers

Parasitemia levelsApicoplast 23S rRNA mutationsRibosomal protein L4 (Rpl4) mutations

Beyond the preview

Go deeper on Plasmodium apicoplast 50S ribosome (Apicoplast 50S).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium apicoplast 50S ribosome (Apicoplast 50S).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call